Published in Atherosclerosis on January 01, 1986
Actin can reorganize into podosomes in aortic endothelial cells, a process controlled by Cdc42 and RhoA. Mol Cell Biol (2003) 1.67
Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol (2006) 1.50
Mechano-chemical control of human endothelium orientation and size. J Cell Biol (1989) 1.33
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
Aortic endothelial cells regulate proliferation of human monocytes in vitro via a mechanism synergistic with macrophage colony-stimulating factor. Convergence at the cyclin E/p27(Kip1) regulatory checkpoint. J Clin Invest (1997) 0.91
Phosphodiesterase-5A (PDE5A) is localized to the endothelial caveolae and modulates NOS3 activity. Cardiovasc Res (2011) 0.83
The seeding of human aortic endothelial cells on the extra-cellular matrix of human umbilical vein endothelial cells. Int J Exp Pathol (1992) 0.78
A Methodology for Concomitant Isolation of Intimal and Adventitial Endothelial Cells from the Human Thoracic Aorta. PLoS One (2015) 0.75
Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach. Oxid Med Cell Longev (2015) 0.75
Enzymatic antioxidant system of endotheliocytes. Dokl Biochem Biophys (2017) 0.75
Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J (1996) 5.50
The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae. Genetics (1994) 4.04
Deletion analysis of the SUP35 gene of the yeast Saccharomyces cerevisiae reveals two non-overlapping functional regions in the encoded protein. Mol Microbiol (1993) 3.76
In vitro propagation of the prion-like state of yeast Sup35 protein. Science (1997) 3.05
Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A (1997) 2.34
Nucleotide sequence of the SUP2 (SUP35) gene of Saccharomyces cerevisiae. Gene (1988) 2.12
Isolation and characterization of actin-like protein from yeast Saccharomyces cerevisiae. FEBS Lett (1979) 2.06
Chaperones that cure yeast artificial [PSI+] and their prion-specific effects. Curr Biol (2000) 1.96
Divergence and conservation of SUP2 (SUP35) gene of yeast Pichia pinus and Saccharomyces cerevisiae. Yeast (1991) 1.72
Red pigment of adenine-deficient yeast Saccharomyces cerevisiae. Biochem Biophys Res Commun (1967) 1.67
Interaction between yeast Sup45p (eRF1) and Sup35p (eRF3) polypeptide chain release factors: implications for prion-dependent regulation. Mol Cell Biol (1997) 1.61
Ribosome-bound EF-1 alpha-like protein of yeast Saccharomyces cerevisiae. Eur J Biochem (1991) 1.49
Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci U S A (1988) 1.38
Mechano-chemical control of human endothelium orientation and size. J Cell Biol (1989) 1.33
Recessive super-suppression in yeast. Mol Gen Genet (1974) 1.29
Studies of energy transport in heart cells. Mitochondrial isoenzyme of creatine phosphokinase: kinetic properties and regulatory action of Mg2+ ions. Eur J Biochem (1975) 1.28
C-terminal truncation of the Sup35 protein increases the frequency of de novo generation of a prion-based [PSI+] determinant in Saccharomyces cerevisiae. Curr Genet (1998) 1.26
Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor. J Clin Invest (1998) 1.25
Recessive nonsense-suppression in yeast: further characterization of a defect in translation. FEBS Lett (1976) 1.24
Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem (1995) 1.21
Morphological alterations in endothelial cells from human aorta and umbilical vein induced by forskolin and phorbol 12-myristate 13-acetate: a synergistic action of adenylate cyclase and protein kinase C activators. Proc Natl Acad Sci U S A (1986) 1.17
[Psi(+)] prion generation in yeast: characterization of the 'strain' difference. Yeast (2001) 1.15
Retarded diffusion of ADP in cardiomyocytes: possible role of mitochondrial outer membrane and creatine kinase in cellular regulation of oxidative phosphorylation. Biochim Biophys Acta (1993) 1.15
A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J Biol Chem (1999) 1.10
Retrospective reconstruction of individual and collective external gamma doses of population evacuated after the Chernobyl accident. Health Phys (1994) 1.09
Role of creatine phosphokinase in cellular function and metabolism. Can J Physiol Pharmacol (1978) 1.09
[Comparison of the DNA polynucleotide sequence of cholera so-called non-agglutinating vibrios]. Zh Mikrobiol Epidemiol Immunobiol (1977) 1.05
Retroviral gene therapy in ApoE-deficient mice: ApoE expression in the artery wall reduces early foam cell lesion formation. Circulation (1999) 1.04
Studies of energy transport in heart cells. The functional coupling between mitochondrial creatine phosphokinase and ATP ADP translocase: kinetic evidence. Arch Biochem Biophys (1976) 1.02
Molecular data from the chloroplast rpoC1 gene suggest a deep and distinct dichotomy of contemporary spermatophytes into two monophyla: gymnosperms (including Gnetales) and angiosperms. J Mol Evol (1999) 1.01
Low vitamin C and increased oxidative stress and cell death in mice that lack the sodium-dependent vitamin C transporter SVCT2. Free Radic Biol Med (2010) 1.00
Cell proliferation in normal and atherosclerotic human aorta. I. Flow cytofluorometric determination of cellular deoxyribonucleic acid content. Lab Invest (1983) 1.00
Calcium-binding rate and capacity of cardiac sarcoplasmic reticulum. J Mol Cell Cardiol (1981) 1.00
Regulation of energy flux through the creatine kinase reaction in vitro and in perfused rat heart. 31P-NMR studies. Biochim Biophys Acta (1984) 1.00
A study of the structure of fibronectin. Eur J Biochem (1981) 1.00
Itt1p, a novel protein inhibiting translation termination in Saccharomyces cerevisiae. BMC Mol Biol (2001) 0.98
Heterogeneity of endothelium in human aorta. A quantitative analysis by scanning electron microscopy. Atherosclerosis (1984) 0.96
Endothelial cell culture on fibrillar collagen: model to study platelet adhesion and liposome targeting to intercellular collagen matrix. Proc Natl Acad Sci U S A (1981) 0.96
Angiosperm origin and early stages of seed plant evolution deduced from rRNA sequence comparisons. J Mol Evol (1991) 0.96
Recessive nonsense-suppression in yeast: involvement of 60S ribosomal subunit. Mol Gen Genet (1978) 0.95
Ribosomal recessive suppressors cause a respiratory deficiency in yeast Saccharomyces cerevisiae. Mol Gen Genet (1982) 0.94
Kinetic properties and the functional role of particulate MM-isoenzyme of creatine phosphokinase bound to heart muscle myofibrils. FEBS Lett (1976) 0.94
Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol (1984) 0.94
Cytomegalovirus genome and the immediate-early antigen in cells of different layers of human aorta. Virchows Arch (2000) 0.92
[Isolation of highly purified phosphoglycerate kinase from rabbit skeletal muscles]. Biokhimiia (1967) 0.92
Evidence of antiatherosclerotic action of verapamil from direct effects on arterial cells. Am J Cardiol (1987) 0.92
Centrosome injury in cells infected with human cytomegalovirus. J Struct Biol (1997) 0.91
Retrovirus-mediated expression of apolipoprotein A-I in the macrophage protects against atherosclerosis in vivo. J Biol Chem (2001) 0.91
Preservation of antimyosin antibody activity after covalent coupling to liposomes. Biochem Biophys Res Commun (1979) 0.91
Study of energy transport mechanism in myocardial cells. Circ Res (1974) 0.90
Cell proliferation in normal and atherosclerotic human aorta. II. Autoradiographic observation on deoxyribonucleic acid synthesis in primary cell culture. Lab Invest (1983) 0.90
Immunohistochemical study of primary and recurrent basal cell and metatypical carcinomas of the skin. Am J Dermatopathol (1996) 0.88
Immunotargeting of erythrocyte-bound streptokinase provides local lysis of a fibrin clot. Biochim Biophys Acta (1986) 0.88
[Structure and functional similarity of yeast Sup35p and Ure2p proteins to mammalian prions]. Mol Biol (Mosk) (1995) 0.87
Catecholamine-mediated injury to endothelium in rabbit perfused aorta: a quantitative analysis by scanning electron microscopy. Cor Vasa (1985) 0.87
Phylogeny of flowering plants by the chloroplast genome sequences: in search of a "lucky gene". Biochemistry (Mosc) (2007) 0.87
Immunoreactive forms of caldesmon in cultivated human vascular smooth muscle cells. FEBS Lett (1987) 0.87
Taurine and electrical activity of the heart. Circ Res (1974) 0.86
The effect of primary products of lipid peroxidation on the transmembrane transport of calcium ions. J Mol Cell Cardiol (1982) 0.86
Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res (1992) 0.86
Translation termination factors function outside of translation: yeast eRF1 interacts with myosin light chain, Mlc1p, to effect cytokinesis. Mol Microbiol (2004) 0.86
Primary culture of human aortic intima cells as a model for testing antiatherosclerotic drugs. Effects of cyclic AMP, prostaglandins, calcium antagonists, antioxidants, and lipid-lowering agents. Atherosclerosis (1986) 0.86
Carrier-directed targeting of liposomes and erythrocytes to denuded areas of vessel wall. Proc Natl Acad Sci U S A (1986) 0.86
Trapidil derivatives as potential antiatherosclerotic drugs. Arzneimittelforschung (1987) 0.86
Analysis of the effectiveness of emergency countermeasures in the 30-km zone during the early phase of the Chernobyl accident. Health Phys (1994) 0.86
Red blood cell targeting to collagen-coated surfaces. FEBS Lett (1983) 0.85
Dibutyryl cyclic AMP decreases proliferative activity and the cholesteryl ester content in cultured cells of atherosclerotic human aorta. Biochem Biophys Res Commun (1982) 0.85
Further characterization of recessive suppression in yeast. Isolation of the low-temperature sensitive mutant of Saccharomyces cerevisiae defective in the assembly of 60 S ribosomal subunit. Biochim Biophys Acta (1981) 0.85
Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content. Acta Anat (Basel) (1983) 0.85
Autoantibodies against modified low density lipoprotein. Nonlipid factor of blood plasma that stimulates foam cell formation. Arterioscler Thromb (1991) 0.85
Electron microscopy study of fibronectin structure. FEBS Lett (1980) 0.85
Localization of possible functional domains in sup2 gene product of the yeast Saccharomyces cerevisiae. FEBS Lett (1987) 0.85
Isolated cells in suspension for biological research--Part III. Structure and functional properties of enterocytes and adipocytes. Exp Pathol (1988) 0.85
On the mechanism of enhanced ATP formation in hypoxic myocardium caused by glutamic acid. Basic Res Cardiol (1985) 0.85
A structural study of filamin, a high-molecular-weight actin-binding protein from chicken gizzard. Eur J Biochem (1982) 0.85
Enzyme immunoassay of the receptors for modified low density lipoprotein. Anal Biochem (1986) 0.84
Flow cytofluorometric study of lipoprotein interactions with cultured endothelial cells. Cytometry (1982) 0.84
An electron microscopic histochemical investigation of the localization of creatine phosphokinase in heart cells. Biochim Biophys Acta (1977) 0.84
High-affinity association and degradation of 125I-labelled low density lipoproteins by human hepatocytes in primary culture. FEBS Lett (1985) 0.84
Study of low density lipoprotein interaction with platelets by flow cytofluorimetry. FEBS Lett (1982) 0.84
Localization of apolipoprotein E in normal and atherosclerotic human aorta. Atherosclerosis (1990) 0.84
Lung is the target organ for a monoclonal antibody to angiotensin-converting enzyme. Lab Invest (1991) 0.84
The principles of enzyme stabilization. IV. Modification of 'key' functional groups in the tertiary structure of proteins. Biochim Biophys Acta (1979) 0.84
A monoclonal antibody, VM64, reacts with a 130 kDa glycoprotein common to platelets and endothelial cells: heterogeneity in antibody binding to human aortic endothelial cells. Thromb Haemost (1991) 0.84
Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol (1986) 0.84